Ten Barcelona players, including Lionel Messi and Xavi Hernandez, underwent “routine” UEFA doping tests yesterday, just days after a Spanish radio station alleged the club had links to disreputable doctors.

“UEFA doctors paid a surprise visit to Barca’s training this morning and carried out routine drug tests on 10 Barca players,” the club said in a statement on its website.

“This is the second time Barca have received one of UEFA’s routine visits this season, after three last year.” The Spanish champions’ players last underwent UEFA doping controls less than a month ago.

The latest tests come after Cadena Cope radio on Sunday said Barcelona rivals Real Madrid had asked the Spanish football federation to take drug testing in the league “more seriously”, saying it does not understand how “doctors with questionable reputations” can work for the Catalan club.

The Catholic radio station, which quoted an unidentified “representative” of Real Madrid, did not name the doctors.

It also alleged that Eufemiano Fuentes, a medical doctor who was one of six people charged in December with trafficking offences in an athletics doping scandal, had worked for Valencia when it won league titles in 2002 and 2004.

Both Barcelona and Valencia have threatened to take legal action against the radio station. Cadena Cope has responded by issuing an apology, saying it did not intend to question the honesty of Barcelona and its players but it has not retracted the report.

“We have an anti-doping control today by UEFA, what a coincidence,” Barcelona defender Gerard Pique, who was one of the 10 players who were tested, said on his Twitter page.

David Villa, Jeffren Suarez, Jose Manuel Pinto, Andres Iniesta, Victor Valdes, Javier Mascherano and Ibrahim Afellay were the other Barcelona players chosen at random to provide urine samples for analysis.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.